HERE: Health Empowerment and Resources After Pregnancy
HERE
2 other identifiers
interventional
60
1 country
1
Brief Summary
This study will examine whether a patient navigation program can help improve long-term heart health among people who experienced high blood pressure disorders during pregnancy at Boston Medical Center (BMC). Conditions such as preeclampsia and other hypertensive disorders of pregnancy increase a person's risk of developing cardiovascular disease later in life. However, many patients do not receive timely follow-up care after pregnancy, especially once routine postpartum care ends. about 60 participants will be randomly assigned to one of two groups. One group will receive standard care, which includes clinician-directed counseling about cardiovascular risk and recommendations for follow-up care. The other group will receive support from a patient navigator in addition to standard care. Patient navigators, also known as Community Wellness Advocates (CWAs), are trained staff who help patients connect with health services, understand their health risks, and navigate the healthcare system. The main goals of the study are to determine whether this navigation program is practical to implement and acceptable to patients and healthcare providers. Researchers will also examine whether the program improves follow-up with primary care, cardiovascular risk assessment, and engagement in heart-healthy behaviors. Information will be collected from medical records, surveys, and interviews with participants and healthcare staff. Participants will be followed for one year
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2026
CompletedFirst Posted
Study publicly available on registry
July 14, 2026
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2028
Study Completion
Last participant's last visit for all outcomes
September 1, 2028
July 14, 2026
July 1, 2026
2 years
June 17, 2026
July 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Acceptability of the intervention
Acceptability, the perception among stakeholders that the intervention is agreeable, will be measured using the 4-item Acceptability of Intervention Measure. Responses will be collected on a 5-point Likert scale (1-5), and the total score will range from 4-20. Total score will be evaluated as a continuous outcome with higher scores indicating greater acceptability. Results will be separately analyzed among participants, navigators, and other clinical staff.
4-6 and 12 months postpartum
Feasibility of the intervention
Feasibility, the extent to which the intervention can be carried out, will be measured using the 4-item Feasibility of Intervention Measure. Responses will be collected on a 5-point Likert scale (1-5), and the total score will range from 4-20. Total score will be evaluated as a continuous outcome with higher scores indicating greater feasibility.
4-6 and 12 months postpartum
Fidelity of the intervention- Penetration
Penetration or "reach" is defined as the percentage of eligible individuals who were screened. This fidelity related metric will be assessed using a protocol-based checklist and electronic health record data for reference monthly
monthly for 12 months postpartum
Fidelity of the intervention- Adherence
Adherence is defined as the percentage of enrolled participants who were supported by the navigator. This fidelity related metric will be assessed using a protocol-based checklist and electronic health record data for reference monthly.
monthly for 12 months postpartum
Secondary Outcomes (7)
Participation Satisfaction
4-6 and 12 months postpartum
Linkage to Primary Care
4-6 and 12 months postpartum
Cardiovascular Health (CVH)
2, 4-6, and 12 months postpartum
Cardiovascular Disease (CVD) Risk Assessment
12 months postpartum
Patient Activation
2, 4-6, and 12 months postpartum
- +2 more secondary outcomes
Study Arms (2)
Postpartum patient navigation
EXPERIMENTALParticipants randomized to this intervention arm will receive longitudinal patient navigation from a Community Wellness Advocate (CWA) who will provide ongoing support after discharge at \~6-8 weeks post partum from the perinatal remote blood pressure monitoring (RBPM) program.
Standard of care
ACTIVE COMPARATORParticipants randomized to this control arm will continue with standard care for a year after discharge from the hospital's perinatal RBPM program at \~6-8 weeks postpartum.
Interventions
A Community Wellness Advocate (CWA) will provide longitudinal patient navigation-proactive check-ins, assistance with appointment attendance scheduling and planning, identification of barriers to care, follow-up after missed appointments, mental health and social needs screening, and connections to appropriate resources. The CWA will serve as a consistent point of contact throughout the postpartum year.
Standard care includes education on postpartum hypertension, a blood pressure cuff for self-monitoring, and assistance with scheduling follow-up care, including referral to a postpartum bridge clinic in General Internal Medicine.
Eligibility Criteria
You may qualify if:
- Gave birth at Boston Medical Center (BMC) in the past 2 months
- Diagnosis of ≥1 hypertensive disorder of pregnancy during their most recent pregnancy
- Active prescription for ≥1 antihypertensive medication
- Scheduled for follow-up in the postpartum bridge clinic at BMC
- Planning to continue using Boston Medical Center for their health care
- Able and willing to provide informed consent and contact information in English, Spanish, or Haitian Creole (CWA will use hospital interpreter services as needed to communicate with patients with a language preference other than English)
You may not qualify if:
- Diagnosed with cardiovascular disease
- Planning pregnancy in next 3 months
- Planning to move out of Massachusetts within the postpartum year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Medical Center
Boston, Massachusetts, 02118, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mara Murray Horwitz, MD, MPH
Boston Medical Center, General Internal Medicine
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 17, 2026
First Posted
July 14, 2026
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
September 1, 2028
Study Completion (Estimated)
September 1, 2028
Last Updated
July 14, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share